Economic Justification Analysis of Minimally Invasive versus Conventional Aortic Valve Replacement
- PMID: 36767915
- PMCID: PMC9916198
- DOI: 10.3390/ijerph20032553
Economic Justification Analysis of Minimally Invasive versus Conventional Aortic Valve Replacement
Abstract
There is no definitive consensus about the cost-effectiveness of minimally invasive aortic valve replacement (AVR) (MI-AVR) compared to conventional AVR (C-AVR). The aim of this study was to compare the rate of postoperative complications and total hospital costs of MI-AVR versus C-AVR overall and by the type of aortic prosthesis (biological or mechanical). Our single-center retrospective study included 324 patients over 18 years old who underwent elective isolated primary AVR with standard stented AV prosthesis at the Institute for Cardiovascular Diseases "Dedinje" between January 2019 and December 2019. Reintervention, emergencies, combined surgical interventions, and patients with sutureless valves were excluded. In both MI-AVR and C-AVR, mechanical valve implantation contributed to overall reduction of hospital costs with equal efficacy. The cost-effectiveness ratio indicated that C-AVR is cheaper and yielded a better clinical outcome with mechanical valve implantation (67.17 vs. 69.5). In biological valve implantation, MI-AVR was superior. MI-AVR patients had statistically significantly higher LVEF and a lower Euro SCORE than C-AVR patients (Mann-Whitney U-test, p = 0.002 and p = 0.002, respectively). There is a slight advantage to MI-AVR vs. C-AVR, since it costs EUR 9.44 more to address complications that may arise. Complications (mortality, early reoperation, cerebrovascular insult, pacemaker implantation, atrial fibrillation, AV block, systemic inflammatory response syndrome, wound infection) were less frequent in the MI-AVR, making MI-AVR more economically justified than C-AVR (18% vs. 22.1%).
Keywords: aortic valve stenosis; cardiac surgical procedures; healthcare economics and organizations; heart valve prosthesis implantation.
Conflict of interest statement
The authors have no conflict of interest to disclose.
Similar articles
-
Sutureless Aortic Valve Replacement for Treatment of Severe Aortic Stenosis: A Single Technology Assessment of Perceval Sutureless Aortic Valve [Internet].Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2017 Aug 25. Report from the Norwegian Institute of Public Health No. 2017-01. Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2017 Aug 25. Report from the Norwegian Institute of Public Health No. 2017-01. PMID: 29553663 Free Books & Documents. Review.
-
Efficacy of sutureless aortic valves in minimally invasive cardiac surgery: an evolution of the surgical technique.J Cardiovasc Surg (Torino). 2017 Oct;58(5):731-738. doi: 10.23736/S0021-9509.16.09503-3. Epub 2016 Jul 6. J Cardiovasc Surg (Torino). 2017. PMID: 27385418
-
Sutureless aortic valve replacement in high risk patients neutralizes expected worse hospital outcome: A clinical and economic analysis.Cardiol J. 2019;26(1):56-65. doi: 10.5603/CJ.a2018.0098. Epub 2018 Sep 20. Cardiol J. 2019. PMID: 30234906 Free PMC article.
-
Full sternotomy versus right anterior minithoracotomy for isolated aortic valve replacement in octogenarians: a propensity-matched study †.Interact Cardiovasc Thorac Surg. 2015 Jun;20(6):732-41; discussion 741. doi: 10.1093/icvts/ivv030. Epub 2015 Mar 10. Interact Cardiovasc Thorac Surg. 2015. PMID: 25757476
-
Do rapid deployment aortic valves improve outcomes compared with surgical aortic valve replacement?Interact Cardiovasc Thorac Surg. 2016 Nov;23(5):814-820. doi: 10.1093/icvts/ivw226. Epub 2016 Jul 1. Interact Cardiovasc Thorac Surg. 2016. PMID: 27371610 Review.
References
-
- Vahanian A., Alfieri O., Andreotti F., Antunes M.J., Barón-Esquivias G., Baumgartner H., Borger M.A., Carrel T.P., De Bonis M., Evangelista A., et al. The joint task force on the management of valvular heart disease of the European Society of cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur. J. Cardio-Thorac. Surg. 2012;42:S1–S44. doi: 10.1093/ejcts/ezs455. - DOI - PubMed
-
- Di Eusanio M., Fortuna D., Cristell D., Pugliese P., Nicolini F., Pacini D., Gabbieri D., Lamarra M. Contemporary outcomes of conventional aortic valve replacement in 638 octogenarians: Insights from an Italian Regional Cardiac Surgery Registry (RERIC) Eur. J. Cardio-Thorac. Surg. 2012;41:1247–1253. doi: 10.1093/ejcts/ezr204. - DOI - PubMed
-
- Brown J.M., O’Brien S.M., Wu C., Sikora J.A.H., Griffith B.P., Gammie J.S. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: Changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J. Thorac. Cardiovasc. Surg. 2009;137:82–90. doi: 10.1016/j.jtcvs.2008.08.015. - DOI - PubMed
-
- Zahn R., Gerckens U., Grube E., Linke A., Sievert H., Eggebrecht H., Hambrecht R., Sack S., Hauptmann K.E., Richardt G., et al. Transcatheter aortic valve implantation: First results from a multi-centre real-world registry. Eur. Heart J. 2011;32:198–204. doi: 10.1093/eurheartj/ehq339. - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources